In last trading session, ZyVersa Therapeutics Inc (NASDAQ:ZVSA) saw 0.45 million shares changing hands with its beta currently measuring 0.80. Company’s recent per share price level of $0.71 trading at $0.03 or 4.86% at ring of the bell on the day assigns it a market valuation of $3.40M. That closing price of ZVSA’s stock is at a discount of -787.32% from its 52-week high price of $6.30 and is indicating a premium of 33.8% from its 52-week low price of $0.47. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.77 million shares which gives us an average trading volume of 3.94 million if we extend that period to 3-months.

ZyVersa Therapeutics Inc (NASDAQ:ZVSA) trade information

Upright in the green during last session for gaining 4.86%, in the last five days ZVSA remained trading in the green while hitting it’s week-highest on Friday, 06/27/25 when the stock touched $0.71 price level, adding 2.74% to its value on the day. ZyVersa Therapeutics Inc’s shares saw a change of -79.93% in year-to-date performance and have moved 10.28% in past 5-day. ZyVersa Therapeutics Inc (NASDAQ:ZVSA) showed a performance of 24.83% in past 30-days. Number of shares sold short was 0.19 million shares which calculate 0.2 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 58.00% during past 5 years.

ZyVersa Therapeutics Inc (NASDAQ:ZVSA)’s Major holders

Insiders are in possession of 0.13% of company’s total shares while institution are holding 7.28 percent of that, with stock having share float percentage of 7.29%. Investors also watch the number of corporate investors in a company very closely, which is 7.28% institutions for ZyVersa Therapeutics Inc that are currently holding shares of the company.